Rachel A. Freedman MD, MPH
Associate Professor of Medicine, Harvard Medical School; Medical Oncologist, Breast Oncology Program, Dana-Farber Cancer Institute, Boston, MADr. Freedman is an Associate Professor of Medicine at the Harvard Medical School; a Medical Oncologist associated with the Breast Oncology Program at the Dana-Farber Cancer Institute in Boston, MA.
Disclosures
Co-author of this manuscript, Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial, my husband is a shareholder in Firefly, a virtual primary care company; and I have led a trial that received institutional funding from Puma Biotechnology. None of these corporate disclosures are relevant to this work.